Skip to content
MarketScale
‹ Back to IndustriesSciences

TMC Vibration Control Contributes To Groundbreaking Cancer Research

TMC Vibration Control has teamed up with Oregon Health and Science University to enhance cancer research through the stabilization of advanced microscopes. By using TMC's Piezoelectric Cancellation System, environmental vibrations that can affect imaging equipment are effectively eliminated. This cooperative effort is key to conducting high-resolution studies on the nanobiology of cancer, potentially leading to better understanding, diagnosis, and treatment of the disease.

This story was produced through MarketScale. See how Sciences teams put it to work with Executive Thought Leadership.

Promoted content from TMC Vibration Control on MarketScale.

By Sciences · CancerClaudia S. LopezDr. Joe W. GrayJessica Riesterer
Share

Key takeaways

01

TMC Vibration Control stabilizes advanced microscopes for high-resolution cancer research.

02

Environmental vibrations can interfere with the accuracy of imaging equipment.

03

Studying diseases at the nanoscale enhances understanding and treatment options.

Get featured

Want to get featured in MarketScale Sciences?

Create a free MarketScale workspace and get your company's expertise featured across our Sciences coverage. No credit card, no demo required.

Start free

TMC Vibration Control has partnered with the Oregon Health and Science University (OHSU) to help stabilize the advanced microscopes OHSU researchers use to study the nanobiology of cancer.

TMC’s technology is essential for high-resolution imaging and accurate scientific research. Vibrations in the environment, such as from traffic, can cause the imaging equipment to shake, which can lead to blurred or distorted images.

The ability to study cells and tissues at the nanoscale level is essential for understanding how they function and how diseases like cancer progress. Understanding these diseases could save millions of lives. In 2023, about 1.9 million new cancer cases are expected to be diagnosed in the U.S. alone. According to the World Health Organization, cancer is a leading cause of death around the world.

TMC Vibration Control is crucial in enabling researchers, like those at OHSU, to develop a deeper understanding of the molecular and cellular mechanisms of disease, ultimately leading to improved diagnosis, treatment, and prevention of diseases.

Some of the researchers at OHSU, including Claudia S. Lopez, Ph.D., Jessica Riesterer, Ph.D. and Dr. Joe W. Gray, Ph.D., and Mike Georgalis, the North American Sales Manager for TMC, explain more about how OHSU and TMC work together to enable the groundbreaking research needed to cure cancer.

Claudia, Jessica, Joe and Mike’s Thoughts:

Claudia: OHSU is Oregon Health and Science University. It’s an academic institution and also a big hospital that serves the Oregon community. At the same time, it has a big research component in the basic science and also in the translational field. Both the local OHSU multiscale Microscopy Core and the Pacific Northwest Cryo-EM Center share the same facility in the basement of the Robertson Life Science Building at OHSU. Access to those facilities is different. While the local facility is a fee for service, the NIH Center is at no cost for those, all of those users having approved projects.

Jessica: As a staff scientist, I assist a lot of the projects as part of the Knight Cancer Institute in looking at the nanobiology of cancer. There’s a big push to look at how cancer cells are organized with their architecture at the cellular level, and so we need the highest resolution in order to do that.

Joe: One of the opportunities with the technologies that we have is to be able to see with few nanometer resolution the features that make up these cells and tissues. The challenge here, of course, is to make these measurements using technologies that run over periods of days to generate the dataset.

Claudia: Having all these microscopes in a good environment is essential. These instruments are very sensitive to vibration, to noise, and to electromagnetic interference.

Jessica: Environmental noise has affected our data, especially in this building. We are surrounded by the light rail, the river, the streetcar. That all affects our imaging.

Claudia: All of our electron microscopes are installed over TMC tables, and that has proven to be essential to be able to operate these instruments at their highest performance possible.

Mike: OHSU deployed the Stasis Active Piezoelectric Cancellation System, which contains sensors inside, which monitor the state of the system, and through active feedback control, they operate piezoelectric actuators, which expand and contract, essentially equally and opposite to the vibration that’s sensed.

Claudia: TMC has helped us mitigate all the vibrations that we have in this facility. On the TMC tables, we are at zero vibrations, which is essential for especially the high-end instruments that we have in the facility.

Jessica: TMC’s vibration control has allowed us to image at the highest resolution, including the nanoscale, and without that, we’d have skewed data.

Joe: We have finally gotten to the point in measurement science that we are able to define the components in the organizations of cells and tissues, and I think it’s going to give us a lot of insight as to how the components work together to actually produce the functions that we observe in the cells and tissues that we look at in the light microscope. So it’s an exciting time, lots to learn, a lot of challenges in terms of interpreting the data, but the measurement tools are there, and I think it’s going to be fun to watch how the field evolves.

Jessica: Cancer affects everyone. Everyone knows someone who’s had it or has it, and to be able to stop that for both the patient and for their loved ones would be life-changing.

Mike: What makes me proud about being at TMC and partnering with organizations like OHSU is that we get to be a small part of the groundbreaking research that’s being performed by Claudia and her colleagues that really has the potential to make an impact on a larger scale.

TMC Vibration Control

Part of this channel

TMC Vibration Control

Precision Instruments and Electromechanical Devices

Visit the channel

Your experts belong here

Every story in MarketScale Sciences starts with a company putting its lab directors, applications scientists, and field specialists on the record. Buyers are already reading this topic. The only question is whose experts they find.

Lab and research buyers verify before they trial, and your scientists give them something credible to verify against.

Get your team featuredSee how it works15 minutes, straight to a calendar.

About the author

S
Sciences

Follow Sciences Insights

Get new expert content in your inbox.

Sciences: are you visible to AI?

Before they reach out, Sciences buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free plan

You just read one Sciences expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your lab directors, applications scientists, and field specialists into the articles, video, and social content Sciences buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale workspace, up to 10 people
One professional video edit a month for qualifying companies
Media requests to your crowd, remote recording, AI writing tools
$0, no credit card, nothing that expires

More Sciences Insights

Pharma supplier diversification means little if every supplier uses the same airport

Pharma supplier diversification means little if every supplier uses the same airport

Biocair's Patrick Wohl argues in Pharmaceutical Commerce that life sciences firms must map airports, sea lanes, customs gateways and carriers alongside suppliers. Suppliers spread across countries can still share one air hub. The fix he describes is pre-qualified alternate routes and continuous review, with clinical trial shipments and cold-chain medicines the first cargo exposed when a corridor closes.

  • 01A supplier base spread across several countries can still be a single point of failure if every shipment routes through one airport hub or corridor; the sharper question for a logistics provider is which hubs each qualified lane actually depends on.
  • 02Gartner data cited by MD+DI gives a benchmark: 42% of procurement leaders rank supply disruption as their organization's top risk, with geopolitical issues including tariffs and regulatory changes ranking third.
  • 03A route map ages fast. Pharmaceutical Commerce published the mapping argument on July 24 and was reporting fresh Red Sea and Iran-related freight risk for pharma lanes by Aug. 10, which is the case for treating mapping as a recurring review rather than a project.

Sep 17, 2026

Resilience and Lilly Invest $750 Million to Increase U.S.-Manufactured Medicine Supply

Resilience and Lilly Invest $750 Million to Increase U.S.-Manufactured Medicine Supply

Resilience and Eli Lilly are investing $750 million to expand KwikPen injectable device production at Resilience's Cincinnati-region manufacturing facility, expected to create 400 high-skilled jobs and reach full operations by early 2027. The partnership builds on their collaboration since 2023, which has already produced over 150 million doses of Lilly medications for the U.S. market.

  • 01$750 million investment to expand Resilience's Ohio manufacturing capacity for Eli Lilly's KwikPen injectable device production
  • 02400 new high-skilled jobs expected in Cincinnati region, with full operations by early 2027
  • 03Partnership has already produced over 150 million doses of Lilly medications for the U.S. market since 2023

Sep 14, 2026

ENEOS ran an AI controller on a distillation column for 35 days and cut steam use 40%

ENEOS ran an AI controller on a distillation column for 35 days and cut steam use 40%

ENEOS Materials and Yokogawa ran an autonomous AI controller on a butadiene distillation column for 35 days and cut steam use 40%. It’s a real operations proof point. It also puts integration and governance gaps front and center.

  • 01A 35-day closed-loop run is a stronger autonomy proof point than a demo, it forces plants to prove handover, fallback, and KPIs over real feed and operating swings.
  • 02Steam reduction claims are compelling, but procurement and ops teams should pin vendors to baselines, operating envelopes, and how off-spec avoidance is measured.
  • 03Agentic AI is showing up as “work management” and “shift checklist” agents before it replaces control engineers, which shifts requirements toward clean, permissioned data access.

Sep 13, 2026

Explore More Sciences Insights

Read more expert perspectives from across Sciences.

Browse Sciences Hub

About the Experts

S
Sciences
CS
Claudia S. Lopez

Ph.D.

Oregon Health and Science University (OHSU)

JR
Jessica Riesterer

Ph.D.

Oregon Health and Science University (OHSU)

DJ
Dr. Joe W. Gray

Ph.D.

Oregon Health and Science University (OHSU)

MG
Mike Georgalis

North American Sales Manager

TMC

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Sciences and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512